Credit Suisse’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $565K | Sell |
74,987
-152,766
| -67% | -$1.15M | ﹤0.01% | 2578 |
|
|
2023
Q4 | $2.11M | Sell |
227,753
-143,079
| -39% | -$1.32M | ﹤0.01% | 1836 |
|
|
2023
Q3 | $3.75M | Sell |
370,832
-42,297
| -10% | -$428K | ﹤0.01% | 1431 |
|
|
2023
Q2 | $5.16M | Buy |
413,129
+50,280
| +14% | +$629K | 0.01% | 1300 |
|
|
2023
Q1 | $4.23M | Buy |
362,849
+96,333
| +36% | +$1.12M | ﹤0.01% | 1409 |
|
|
2022
Q4 | $2.83M | Buy |
266,516
+497
| +0.2% | +$5.28K | ﹤0.01% | 1664 |
|
|
2022
Q3 | $2.58M | Sell |
266,019
-213,601
| -45% | -$2.07M | ﹤0.01% | 1659 |
|
|
2022
Q2 | $6.95M | Sell |
479,620
-114,205
| -19% | -$1.65M | 0.01% | 1093 |
|
|
2022
Q1 | $15.5M | Buy |
593,825
+153,313
| +35% | +$4.01M | 0.01% | 857 |
|
|
2021
Q4 | $17.5M | Buy |
440,512
+151,587
| +52% | +$6.01M | 0.01% | 845 |
|
|
2021
Q3 | $14.4M | Buy |
288,925
+55,642
| +24% | +$2.78M | 0.01% | 951 |
|
|
2021
Q2 | $12.9M | Sell |
233,283
-24,010
| -9% | -$1.33M | 0.01% | 1018 |
|
|
2021
Q1 | $12M | Sell |
257,293
-20,567
| -7% | -$962K | 0.01% | 1081 |
|
|
2020
Q4 | $12.1M | Sell |
277,860
-21,165
| -7% | -$921K | 0.01% | 1038 |
|
|
2020
Q3 | $10.9M | Sell |
299,025
-70,601
| -19% | -$2.58M | 0.01% | 957 |
|
|
2020
Q2 | $10.8M | Buy |
369,626
+328,562
| +800% | +$9.58M | 0.01% | 959 |
|
|
2020
Q1 | $1.07M | Buy |
41,064
+13,316
| +48% | +$348K | ﹤0.01% | 2064 |
|
|
2019
Q4 | $963K | Sell |
27,748
-25,780
| -48% | -$895K | ﹤0.01% | 2538 |
|
|
2019
Q3 | $1.69M | Buy |
+53,528
| New | +$1.69M | ﹤0.01% | 2046 |
|